Garry Steil

Dr. Steil received a Ph.D. in Physiology and Biophysics from the University in Southern California, in Los Angeles California. Prior to receiving his Ph.D. he received a B.Sc. and a M.Sc., both in Electrical Engineering, from the University of Alberta in Edmonton Alberta Canada. He also worked as postdoctoral fellow at the Joslin Diabetes Center in Boston looking for new ways to transplant islets (another approach to addressing the insulin deficiency in type 1 diabetes), as well as in industry where he sought to develop the first commercially available artificial pancreas that could be made widely available to individuals with the disease.

Companies

• Associate Professor of Pediatrics Harvard Medical School (2020)
• Scientist Children's Hospital Boston (2008)
• Assistant Professor of Pediatrics Harvard Medical School (2009 — 2020)

Publications

Performance of an Electronic Decision Support System as a Therapeutic Intervention During a Multicenter PICU Clinical Trial: Heart and Lung Failure-Pediatric Insulin Titration Trial (HALF-PINT). Chest. 2021 09; 160(3):919-928. ViewPerformance of an Electronic Decision Support System as a Therapeutic Intervention During a Multicenter PICU Clinical Trial: Heart and Lung Failure-Pediatric Insulin Titration Trial (HALF-PINT). Abstract

Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial. Diabetes Care. 2020 01; 43(1):59-66. ViewAmount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial. Abstract

Short-Term Adverse Outcomes Associated With Hypoglycemia in Critically Ill Children. Crit Care Med. 2019 05; 47(5):706-714. ViewShort-Term Adverse Outcomes Associated With Hypoglycemia in Critically Ill Children. Abstract

Continuous Glucose Monitoring Linked to an Artificial Intelligence Risk Index: Early Footprints of Intraventricular Hemorrhage in Preterm Neonates. Diabetes Technol Ther. 2019 03; 21(3):146-153. ViewContinuous Glucose Monitoring Linked to an Artificial Intelligence Risk Index: Early Footprints of Intraventricular Hemorrhage in Preterm Neonates. Abstract

Adjusting Insulin Delivery to Activity (AIDA) clinical trial: Effects of activity-based insulin profiles on glucose control in children with type 1 diabetes. Pediatr Diabetes. 2018 12; 19(8):1451-1458. ViewAdjusting Insulin Delivery to Activity (AIDA) clinical trial: Effects of activity-based insulin profiles on glucose control in children with type 1 diabetes. Abstract